Nano-X Imaging Ltd. NNOX
Nanox's $1.3B medical-imaging story is a stock promotion: the ARC device appears to be a prop, distribution partnerships are shams, and a convicted felon engineered the IPO.
Thesis
Muddy Waters is short Nano-X Imaging (NNOX), arguing the company's $1.3B valuation rests on a fabricated medical-imaging story. Four of five interviewed radiologists compared NNOX to Theranos, and the firm's 'live demo' video appears to show borrowed or reconstructed CT images rather than footage from the ARC device itself — which radiologists say is incapable of the claimed tomosynthesis. NNOX touts $180.8M in annual distribution commitments, but partners include shell-like entities in Russia, Italy, South Africa and Spain that lack the cash, facilities or track record to fulfill them. The IPO was orchestrated by boutique banker A-Labs, allegedly controlled by convicted Israeli fraudster Eli Reifman, who served four years in prison for forgery. CEO Ran Poliakine has no medical or physics background, never graduated from art school, and faces fraud allegations in prior ventures including Powermat.
SCQA
Nano-X Imaging IPO'd in August 2020 at a $1.3B market cap on claims its ARC device will revolutionize radiology with low-cost digital X-rays, backed by SK Telecom, Hadassah Hospital, and $180.8M in distribution commitments.
Radiologists say the ARC cannot produce the images shown in NNOX's demo video, which appears to splice borrowed CT scans; partners are shell entities; the IPO was architected by a boutique secretly run by convicted Israeli fraudster Eli Reifman.
Muddy Waters is publicly short the stock and calls on investors, auditors and regulators to scrutinize the fabricated demo, the sham distribution partnerships, the felon-architect behind A-Labs, and CEO Poliakine's lack of qualifications.
No price target is disclosed, but Muddy Waters concludes NNOX 'has no real product to sell other than its stock,' calling it 'a much bigger piece of garbage than Nikola will ever be' — implying the equity is worth substantially zero.
The three reasons
- 1
Demo video's chest images look faked — radiologists say the ARC cannot perform the claimed CT imaging.
- 2
$180.8M in distribution partnerships are shell-like entities incapable of delivering the stated volumes.
- 3
Stock promotion architect A-Labs is secretly controlled by convicted Israeli fraudster Eli Reifman.
Primary demands
- Investors should recognize NNOX as a stock promotion built around a non-functional device
- NNOX should explain why its demo video images appear to come from different subjects
- NNOX should disclose the involvement of convicted felon Eli Reifman in its IPO and operations
- Regulators and the market should scrutinize the $180.8M in purported distribution commitments
KPIs cited
Pattern membership
Where this document fits across the library's 12 rhetorical / structural patterns.
Precedents cited
- Nikola (truck rolled down hill to fake propulsion)
- Theranos (four of five radiologists unprompted invoked Theranos)
- Emblaze (Reifman's prior dotcom-era fraud and forgery)
- Powermat (Poliakine lawsuit alleging improper management)
Notable slides (6)
Notes
Classic Muddy Waters fraud-exposure prose memo (Word/PDF, not slides) — opens with 'Star Trek, Thernaos, and Nikola' framing and an employee quote from the purported AI partner. Heavy reliance on forensic evidence: radiologist interviews, LinkedIn screenshots (Reifman's prison tenure), corporate registry records linking Reifman relative to A-Labs, address-lookup data placing Reifman at the same address as the A-Labs GP. Report explicitly invokes Nikola (truck rolled down hill) and Theranos as analogues — unusually blunt precedent-citing. No slides, charts, or SOTP valuation — the 'valuation' is rhetorical ('no real product to sell other than its stock'). Notable pages: p2 cover-thesis, p5 phantom-with-arms-up photo, p6 circled-collarbone X-ray showing image mismatch, p9 Reifman LinkedIn 'Prisoner' entry, p12 ARC prototype vs. sci-fi rendering comparison, p41 sci-fi prop render by Jurassic-World designer. Stake size not disclosed.